Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.

Chelladurai Y, Suarez-Cuervo C, Erekosima N, Kim JM, Ramanathan M, Segal JB, Lin SY.

J Allergy Clin Immunol Pract. 2013 Jul-Aug;1(4):361-9. doi: 10.1016/j.jaip.2013.04.005. Epub 2013 Jun 4. Review.

PMID:
24565541
2.

Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.

Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, Lin SY.

Laryngoscope. 2014 Mar;124(3):616-27. doi: 10.1002/lary.24295. Epub 2013 Aug 5. Review.

PMID:
23832632
3.

Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.

Kim JM, Lin SY, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, Erekosima N.

Pediatrics. 2013 Jun;131(6):1155-67. doi: 10.1542/peds.2013-0343. Epub 2013 May 6. Review.

4.

Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.

Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB.

JAMA. 2013 Mar 27;309(12):1278-88. doi: 10.1001/jama.2013.2049. Review. Erratum in: JAMA. 2013 Aug 14;310(6):647.

PMID:
23532243
5.

Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review.

Röder E, Berger MY, de Groot H, van Wijk RG.

Pediatr Allergy Immunol. 2008 May;19(3):197-207. doi: 10.1111/j.1399-3038.2007.00648.x. Epub 2008 Jan 24. Review.

PMID:
18221463
6.

Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.

Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.

Respir Med. 2013 Sep;107(9):1322-9. doi: 10.1016/j.rmed.2013.06.021. Epub 2013 Jul 23.

7.

Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?

Nelson HS.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):144-9; quiz 150-1. doi: 10.1016/j.jaip.2013.11.018. Review.

PMID:
24607040
9.

Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review [Internet].

Lin SY, Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Ward D, Chelladurai Y, Segal JB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Mar.

10.

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.

Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C, Barton P, Dretzke J.

Health Technol Assess. 2013 Jul;17(27):vi, xi-xiv, 1-322. doi: 10.3310/hta17270. Review.

11.

Specific immunotherapy-indications and mode of action.

Brehler R, Klimek L, Kopp MV, Christian Virchow J.

Dtsch Arztebl Int. 2013 Mar;110(9):148-58. doi: 10.3238/arztebl.2013.0148. Epub 2013 Mar 1.

12.

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

Calderon MA, Casale TB, Nelson HS, Demoly P.

J Allergy Clin Immunol. 2013 Dec;132(6):1322-36. doi: 10.1016/j.jaci.2013.09.004. Epub 2013 Oct 18. Review.

PMID:
24139829
13.

Effectiveness of subcutaneous versus sublingual immunotherapy for allergic rhinitis: current update.

Chelladurai Y, Lin SY.

Curr Opin Otolaryngol Head Neck Surg. 2014 Jun;22(3):211-5. doi: 10.1097/MOO.0000000000000045. Review.

PMID:
24732432
14.

Sublingual immunotherapy for treating allergic conjunctivitis.

Calderon MA, Penagos M, Sheikh A, Canonica GW, Durham S.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007685. doi: 10.1002/14651858.CD007685.pub2. Review.

PMID:
21735416
15.

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.

Nelson H, Cartier S, Allen-Ramey F, Lawton S, Calderon MA.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):256-266.e3. doi: 10.1016/j.jaip.2014.09.018. Epub 2014 Nov 20. Review.

PMID:
25609326
16.

Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.

Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C.

J Allergy Clin Immunol. 2013 May;131(5):1361-6. doi: 10.1016/j.jaci.2013.02.013. Epub 2013 Apr 1. Review.

PMID:
23557834
17.

Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.

Bahceciler NN, Cobanoglu N.

Immunotherapy. 2011 Jun;3(6):747-56. doi: 10.2217/imt.11.48. Review.

PMID:
21668312
18.

Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.

Creticos PS, Esch RE, Couroux P, Gentile D, D'Angelo P, Whitlow B, Alexander M, Coyne TC.

J Allergy Clin Immunol. 2014 Mar;133(3):751-8. doi: 10.1016/j.jaci.2013.10.041. Epub 2013 Dec 12. Erratum in: J Allergy Clin Immunol. 2014 May;133(5):1502.

PMID:
24332263
19.

Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy.

Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB.

Asian Pac J Allergy Immunol. 2013 Sep;31(3):233-41. doi: 10.12932/AP0276.31.3.2013.

20.

Patient initiation and persistence with allergen immunotherapy.

Anolik R, Schwartz AM, Sajjan S, Allen-Ramey F.

Ann Allergy Asthma Immunol. 2014 Jul;113(1):101-7. doi: 10.1016/j.anai.2014.04.008. Epub 2014 May 9.

PMID:
24814759
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk